These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 26177447)

  • 21. Synthesis, crystal structures, DNA binding and cytotoxicity of two novel platinum(II) complexes containing 2-(hydroxymethyl)pyridine and pyridine-2-carboxylate ligands.
    Icsel C; Yilmaz VT; Golcu A; Ulukaya E; Buyukgungor O
    Bioorg Med Chem Lett; 2013 Apr; 23(7):2117-22. PubMed ID: 23434229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A glucose derivative as natural alternative to the cyclohexane-1,2-diamine ligand in the anticancer drug oxaliplatin?
    Berger I; Nazarov AA; Hartinger CG; Groessl M; Valiahdi SM; Jakupec MA; Keppler BK
    ChemMedChem; 2007 Apr; 2(4):505-14. PubMed ID: 17340670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toward overcoming cisplatin resistance via sterically hindered platinum(II) complexes.
    Yu H; Gou S; Wang Z; Chen F; Fang L
    Eur J Med Chem; 2016 May; 114():141-52. PubMed ID: 26974381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and in vitro characterization of platinum(II) anticancer coordinates using FTIR spectroscopy and NCI COMPARE: A fast method for new compound discovery.
    Berger G; Leclercqz H; Derenne A; Gelbcke M; Goormaghtigh E; Nève J; Mathieu V; Dufrasne F
    Bioorg Med Chem; 2014 Jul; 22(13):3527-36. PubMed ID: 24818960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation of antitumor oxaliplatin/cisplatin docking dinuclear platinum complex.
    Noji M; Kizu R; Takeda Y; Akiyama N; Yoshizaki I; Eriguchi M; Kidani Y
    Biomed Pharmacother; 2005 Jun; 59(5):224-9. PubMed ID: 15919175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis of two platinum(II) complexes with 2-methyl-8-quinolinol derivatives as ligands and study of their antitumor activities.
    Qin QP; Wang SL; Tan MX; Liu YC; Meng T; Zou BQ; Liang H
    Eur J Med Chem; 2019 Jan; 161():334-342. PubMed ID: 30384040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis of a platinum(II) complex with 2-(4-methoxy-phenyl) imidazo [4,5-f]-[1,10] phenanthrolin and study of its antitumor activity.
    Qin QP; Chen ZF; Shen WY; Jiang YH; Cao D; Li YL; Xu QM; Liu YC; Huang KB; Liang H
    Eur J Med Chem; 2015 Jan; 89():77-87. PubMed ID: 25462228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An in vivo active 1,2,5-oxadiazole Pt(II) complex: A promising anticancer agent endowed with STAT3 inhibitory properties.
    Porta F; Facchetti G; Ferri N; Gelain A; Meneghetti F; Villa S; Barlocco D; Masciocchi D; Asai A; Miyoshi N; Marchianò S; Kwon BM; Jin Y; Gandin V; Marzano C; Rimoldi I
    Eur J Med Chem; 2017 May; 131():196-206. PubMed ID: 28324784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
    Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
    Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of chirality on the anticancer activity of Pt(II) and Pt(IV) complexes containing 1
    Papadia P; Barbanente A; Ditaranto N; Hoeschele JD; Natile G; Marzano C; Gandin V; Margiotta N
    Dalton Trans; 2021 Nov; 50(43):15655-15668. PubMed ID: 34673864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis, cytotoxicity and antitumor activity of platinum(II) complexes of cyclopentanecarboxylic acid hydrazide.
    Kushev D; Gorneva G; Taxirov S; Spassovska N; Grancharov K
    Biol Chem; 1999 Nov; 380(11):1287-94. PubMed ID: 10614821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel oxaliplatin derivatives with 1-(substituted benzyl)azetidine-3,3-dicarboxylate anions. Synthesis, cytotoxicity, and interaction with DNA.
    Sun Y; Cao Z; Gou S; Hu T
    Chem Biodivers; 2014 Jan; 11(1):115-25. PubMed ID: 24443431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. trans-Dichloridopalladium(II) and platinum(II) complexes with 2-(hydroxymethyl)pyridine and 2-(2-hydroxyethyl)pyridine: synthesis, structural characterization, DNA binding and in vitro cytotoxicity studies.
    Icsel C; Yilmaz VT; Ari F; Ulukaya E; Harrison WT
    Eur J Med Chem; 2013 Feb; 60():386-94. PubMed ID: 23314052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and characterization of platinum(II) oxadiazoline complexes and their in vitro antitumor activity in platinum-sensitive and -resistant cancer cell lines.
    Coley HM; Sarju J; Wagner G
    J Med Chem; 2008 Jan; 51(1):135-41. PubMed ID: 18072719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Homo- and heteroleptic Pt(II) complexes of ONN donor hydrazone and 4-picoline: A synthetic, structural and detailed mechanistic anticancer investigation.
    Rahman FU; Bhatti MZ; Ali A; Duong HQ; Zhang Y; Yang B; Koppireddi S; Lin Y; Wang H; Li ZT; Zhang DW
    Eur J Med Chem; 2018 Jan; 143():1039-1052. PubMed ID: 29232581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis, antiproliferative activity and DNA binding study of mixed ammine/cyclohexylamine platinum(II) complexes with 1-(substituted benzyl) azetidine-3, 3-dicarboxylates.
    Sun Y; Gou S; Yin R; Jiang P
    Eur J Med Chem; 2011 Oct; 46(10):5146-53. PubMed ID: 21875765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. trans,cis,cis-bis(benzoato)dichlorido(cyclohexane-1R,2R-diamine)platinum(IV): a prodrug candidate for the treatment of oxaliplatin-refractory colorectal cancer.
    Gandin V; Marzano C; Pelosi G; Ravera M; Gabano E; Osella D
    ChemMedChem; 2014 Jun; 9(6):1299-305. PubMed ID: 24715720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and biological studies of pyrazolyl-diamine Pt(II) complexes containing polyaromatic DNA-binding groups.
    Gama S; Mendes F; Esteves T; Marques F; Matos A; Rino J; Coimbra J; Ravera M; Gabano E; Santos I; Paulo A
    Chembiochem; 2012 Nov; 13(16):2352-62. PubMed ID: 23038670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A cancer specific oxaliplatin-releasing Pt(iv)-prodrug.
    Reshetnikov V; Arkhypov A; Julakanti PR; Mokhir A
    Dalton Trans; 2018 May; 47(19):6679-6682. PubMed ID: 29708261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coordination-driven self-assembly of a Pt(iv) prodrug-conjugated supramolecular hexagon.
    Yue Z; Wang H; Li Y; Qin Y; Xu L; Bowers DJ; Gangoda M; Li X; Yang HB; Zheng YR
    Chem Commun (Camb); 2018 Jan; 54(7):731-734. PubMed ID: 29303526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.